D-0483-2026 Class II Ongoing
FDA drug recall D-0483-2026 was initiated by International Medication Systems Ltd. on Apr 1, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 81,520 units.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 22, 2026
- Initiation Date
- Apr 1, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 81,520 units
Product description
EPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only, INTERNATIONAL MEDICATION SYSTEMS, LIMITED, So. EL Monte, CA 91733, An Amphastar Pharmaceutical Company, NDC 76329-3318-1
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
U.S. Nationwide
Code information
Lot Number: EA038A5, Expiration Date: 08/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0483-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026